WT1 and breast carcinoma: In 2002, Zapata-Benavides et al. 42 found that stimulating breast cancer cell proliferation with 17β-estradiol significantly increased WT1 protein expression, while, tamoxifen or all-trans retinoic acid could inhibit cell proliferation.